Skip to main content
Clinical Trials/JPRN-UMIN000032055
JPRN-UMIN000032055
Completed
未知

tudy on Biomarkers Using Circulating Tumor Cells When Administering Osimertinib in Patients with EGFR Mutation-positive Lung Cancer - CTC-BIOME

Toho University0 sites50 target enrollmentApril 2, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Toho University
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 2, 2018
End Date
March 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients with complications or a history of serious lung disorder 2\) Patients with intermediate or serious liver disorder 3\) Patients with complications or a history of serious QT prolongation (QTc value longer than 500msec, symptom of serious arrhythmia) 4\) Pregnant women, women who may possibly be pregnant, women who hope to be pregnant, lactating women and men who declined contraception 5\) Patients positive for human immunodeficiency virus (HIV) 6\) Patients positive for HBs antigen or hepatitis C virus (HCV RNA) 7\) Other patients considered as

Outcomes

Primary Outcomes

Not specified

Similar Trials